Profile: Noven Pharmaceuticals Inc develops advanced transdermal drug delivery technologies & prescription transdermal products. Our Vivelle® aids in the treatment of menopausal symptoms & for the prevention of osteoporosis. Our Vivelle-Dot™ is indicated for the treatment of the symptoms of menopause & the prevention of postmenopausal osteoporosis, which is available in five dosage strengths & the 0.025 dosage strength is indicated for the prevention of postmenopausal osteoporosis. Our transdermal testosterone is indicated for hypoactive sexual desire disorder in women. Our Stavzor® valporic acid is indicated for bipolar disorder, migraine and epilepsy.